RXO, Inc. RXO
28.24 USD +0.42 (+1.51%)
At closeNov 3, 2026, 4:00 PM EST
28.24 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
27.77 Day range 28.38
10.43 52-week range 29.90
- YTD
- +123.42%
- 1 year
- +60.27%
- Market cap
- 4.66B
- Revenue (ttm)
- 6.54B
- Profit margin
- -1.35%
- EPS (ttm)
- -0.52
- Shares out
- 164.95M
- Forward P/E
- 42.86
- YTD return
- +123.42%
- 1-year return
- +60.27%
- Volume
- 1.91M
- Avg volume
- 2.79M
- Open
- 27.89
- Previous close
- 27.82
- Day's range
- 27.77 – 28.38
- 52-week range
- 10.43 – 29.90
- Beta
- 1.85
- Analysts
- Hold
- Price target
- 27.96 (-1.0%)
- Earnings date
- Feb 5, 2027
2Y +0.40 (+1.43%)
Key statistics
- Enterprise value
- 5.29B
- PEG ratio
- 172.13
- Price / sales
- 0.71
- Price / book
- 3.07
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 31.70%
- Free cash flow
- -7.13M
- Total cash
- 25.00M
- Total debt
- 727.00M
- Return on equity
- -5.68%
- Short % of float
- 18.78%
- 50-day average
- 23.86
- 200-day average
- 21.11
Analyst view
Consensus: hold
Hold
Price target (mean) 27.96 -1.0% downside
Now 28.24
- Target (low)
- 19.00
- Target (mean)
- 27.96
- Target (high)
- 33.00
Ratings (0m) 18 3 buy · 15 hold · 0 sell
- Strong buy1
- Buy2
- Hold15
- Sell0
- Strong sell0
Next earnings
Feb 5, 2027
Expected Feb 5, 2027. Consensus EPS estimate 0.09852.
Financials — quick view
RXO Revenue — quarterly 1.87B
RXO Net income — quarterly 3.00M
RXO EPS — quarterly 0.02
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 5, 2027 | Dec 30, 2026 | 0.10 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 0.07864 | 0.09 | +0.01 | +14.45% |
| Aug 6, 2026 | Jun 30, 2026 | 0.03588 | 0.06 | +0.02 | +67.22% |
| May 7, 2026 | Mar 31, 2026 | -0.09 | -0.09 | 0.00 | 0.00% |
| Feb 6, 2026 | Dec 31, 2025 | -0.04 | -0.07 | -0.03 | -75.00% |
| Nov 6, 2025 | Sep 30, 2025 | 0.03 | 0.01 | -0.02 | -66.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Susquehanna | main | Neutral | Neutral |
| Oct 7, 2026 | Truist Securities | main | Buy | Buy |
| Oct 6, 2026 | Citigroup | main | Neutral | Neutral |
| Oct 6, 2026 | TD Cowen | up | Sell | Hold |
| Oct 6, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Oct 6, 2026 | JP Morgan | up | Underweight | Neutral |
About RXO, Inc.
RXO, Inc. engages in truck brokerage business in the United States, Canada, Mexico, Asia, and Europe. It offers truckload freight brokering services. The company also provides asset-light managed transportation and last mile services, as well as freight forwarding services, including facilitation of ocean and air transportation, customs brokerage, and additional domestic services including middle mile. RXO, Inc. was incorporated in 2022 and is headquartered in Charlotte, North Carolina.
- Sector
- Industrials
- Industry
- Trucking
- Country
- United States
- Website
- rxo.com
News
Susquehanna Maintains Neutral on RXO, Raises Price Target to $30 
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR) 
RXO (RXO) Reports Q3 Earnings: What Key Metrics Have to Say 
RXO (RXO) Q3 Earnings and Revenues Top Estimates 
12 Industrials Stocks Moving In Thursday's Pre-Market Session 
RXO Q3 Adj. EPS $0.09 Beats $0.07 Estimate, Sales $1.871B Beat $1.808B Estimate 
RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains 
Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock 
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders? 
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
Your note
Sign in to keep a note on RXO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BRADLEY S JACOBS | Director | Conversion of Exercise of derivative security | Jan 1, 2025 | 2,362,920 |
| COOPER TROY A | Director | Conversion of Exercise of derivative security | Jan 1, 2026 | 283,161 |
| FIRESTONE JEFFREY D. | Officer | Conversion of Exercise of derivative security | Aug 20, 2026 | 117,276 |
| HARRIS JAMES E | Chief Financial Officer | Conversion of Exercise of derivative security | Sep 24, 2026 | 166,402 |
| KERR JASON S. | Officer | Conversion of Exercise of derivative security | Mar 19, 2026 | 48,443 |
| KINGSHOTT ADRIAN P | Director | Purchase | Nov 16, 2025 | 91,137 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbis Allan Gray Ltd | 22.07% | 36,397,974 | 1.03B | Jun 29, 2026 |
| MFN Partners Management, LP | 17.04% | 28,109,942 | 794.39M | Jun 29, 2026 |
| Blackrock Inc. | 15.24% | 25,135,757 | 710.34M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.63% | 9,290,827 | 262.56M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.50% | 7,430,859 | 210.00M | Jun 29, 2026 |
| State Street Corporation | 4.04% | 6,658,205 | 188.16M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 9,820,678 | 277.53M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 5,233,866 | 147.91M | Jun 29, 2026 |
| Manager Directed Portfolios-Hood River Small-Cap Growth Fund | 2.91% | 4,805,843 | 135.81M | Jul 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.63% | 4,337,522 | 122.58M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 3,783,643 | 106.93M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.32% | 2,178,434 | 61.56M | Jun 29, 2026 |